# Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

> **NCT00031473** · PHASE3 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 90 (—)

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** Virazole (Ribavirin) Inhalation Solution

## Key facts

- **NCT ID:** NCT00031473
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-11
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 90 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031473, "Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT00031473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*